ADMA Biologics engages KPMG as new auditor effective after Q3 2024 10-Q filing

ADMA BIOLOGICS, INC.

KPMG appointed as independent registered public accounting firm on October 31, 2024, effective upon filing of Q3 2024 10-Q.
No consultations or disagreements with KPMG during prior fiscal years 2022-2023 and interim period through October 31, 2024.
KPMG will audit the consolidated financial statements for FY 2024, expected to be filed by March 3, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.